Recent Posts
- NITYR (nitisinone) Tablets for tyrosinaemia type 1 will be available with fully subsidised access on the Life Saving Drugs Program across Australia
- Cycle Pharmaceuticals’ NITYR (nitisinone) tablets receives marketing authorization in Chile
- Longer shelf life for NITYR (nitisinone) tablets for HT-1 in the U.S. granted by the FDA
- Cycle Pharmaceuticals Receives Approval for Updated Infant Administration for NITYR (nitisinone) Tablets for HT-1 in U.S.
- Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.
Archives
- No comments have been published yet.
Find us on Facebook
Archives
Recent Posts
- NITYR (nitisinone) Tablets for tyrosinaemia type 1 will be available with fully subsidised access on the Life Saving Drugs Program across Australia
- Cycle Pharmaceuticals’ NITYR (nitisinone) tablets receives marketing authorization in Chile
- Longer shelf life for NITYR (nitisinone) tablets for HT-1 in the U.S. granted by the FDA
- Cycle Pharmaceuticals Receives Approval for Updated Infant Administration for NITYR (nitisinone) Tablets for HT-1 in U.S.
- Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.
Recent Tweets
-
Happy anniversary @envato and wishing you an awesome year to come! @Theme_Fusion @jamesgiroux @StephenCronin
6 hours ago -
@Kris_Sangani NO worries, Kris. We are on the case and as you have seen, been communicating via the ticket. We will… twitter.com/i/web/status/1…
19 hours ago -
@Kris_Sangani Thank you Kris. Your ticket is in progress, thank you for the correct credentials so that we can log… twitter.com/i/web/status/1…
20 hours ago
Recent Comments